Pfizer ended last year with 81,000 employees worldwide, down 8% from 2023. “After years of falling Covid treatment sales, lukewarm drug launches and a fizzled-out weight-loss play, ...

Pfizer (PFE) reported mixed first quarter earnings Tuesday, as the company focuses on gaining investor interest in its near-term pipeline amid a volatile macro environment in the markets. Pfizer ...

The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at rival Pfizer, had told his GSK colleagues about the delay.

Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating a claim about the timing of Pfizer's COVID-19 vaccine announcement.

Feds probe disputed tip Pfizer held Covid vaccine results until after 2020 vote: WSJ President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the ...

Pfizer’s PFE 2024 revenue reached $63.6 billion, near the high end of its $61 billion-$64 billion guidance range. Management reaffirmed expectations for 2025 revenue of $61 billion-$64 billion ...

Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO Jeff Smith.

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management under CEO Albert Bourla. Yale SOM’s Jeffrey Sonnenfeld and co-author Steven ...

After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump. A big shareholder, Starboard Value, has alleged Pfizer interfered in its efforts to drive change by working with two ...

Given its better valuation, we believe that Pfizer stock (NYSE: PFE) is currently a better pick than its industry peer – AbbVie stock . PFE stock trades at a much lower multiple of 11x forward ...

Pfizer’s top scientist Mikael Dolsten is stepping down after leading the drugmaker’s research and development for the past 15 years, a period that includes Pfizer’s remarkable success developing a ...

Pfizer is pushing to be more involved in cancer drugs after a turbulent year marked by the rapid decline of its COVID business. During a four-hour investor event last week, Pfizer pushed its initat… ...